ストックスクリーナーアプリを入手
38.72
3.99%
-1.61
アフターアワーズ：
38.72
前日終値:
$40.33
開ける：
$40.13
24時間の取引高:
259.58K
Relative Volume:
0.81
時価総額：
$1.16B
収益：
$17.16M
当期純損益:
$-163.62M
株価収益率:
-7.4605
EPS:
-5.19
ネットキャッシュフロー:
$-121.61M
1週間 パフォーマンス:
+8.84%
1か月 パフォーマンス:
+13.88%
6か月 パフォーマンス:
+65.12%
1年 パフォーマンス:
+98.56%
1日の値動き範囲:
$38.15
$40.55
1週間の範囲:
$34.38
$40.70
52週間の値動き範囲:
$13.36
$41.31
Anaptysbio Inc Stock (ANAB) Company Profile
名前
Anaptysbio Inc
セクター
電話
858-362-6295
住所
10770 WATERIDGE CIRCLE, SUITE 210, SAN DIEGO, CA
Anaptysbio Inc Stock (ANAB) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-05-22 | アップグレード | JP Morgan | Underweight → Neutral |
| 2023-05-18 | 開始されました | TD Cowen | Outperform |
| 2023-01-06 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2022-11-01 | アップグレード | Guggenheim | Neutral → Buy |
| 2022-09-19 | 再開されました | H.C. Wainwright | Buy |
| 2022-09-13 | ダウングレード | Truist | Buy → Hold |
| 2022-09-01 | 開始されました | Raymond James | Outperform |
| 2022-03-22 | ダウングレード | Guggenheim | Buy → Neutral |
| 2021-06-22 | 開始されました | H.C. Wainwright | Buy |
| 2021-05-21 | 開始されました | UBS | Neutral |
| 2021-03-16 | アップグレード | Truist | Hold → Buy |
| 2021-03-09 | ダウングレード | Wedbush | Outperform → Neutral |
| 2021-03-08 | ダウングレード | JP Morgan | Overweight → Underweight |
| 2021-02-11 | アップグレード | JP Morgan | Underweight → Overweight |
| 2020-10-27 | アップグレード | Wedbush | Neutral → Outperform |
| 2020-10-14 | アップグレード | Guggenheim | Neutral → Buy |
| 2019-11-08 | ダウングレード | JP Morgan | Overweight → Underweight |
| 2019-11-08 | ダウングレード | Jefferies | Buy → Hold |
| 2019-11-08 | ダウングレード | SunTrust | Buy → Hold |
| 2019-11-08 | ダウングレード | Wedbush | Outperform → Neutral |
| 2019-06-21 | ダウングレード | Credit Suisse | Outperform → Neutral |
| 2019-06-21 | ダウングレード | Stifel | Buy → Hold |
| 2018-12-20 | 開始されました | H.C. Wainwright | Buy |
| 2018-11-21 | 開始されました | JP Morgan | Overweight |
| 2018-07-19 | 開始されました | Credit Suisse | Outperform |
| 2018-04-04 | ダウングレード | RBC Capital Mkts | Outperform → Sector Perform |
| 2018-03-27 | 繰り返されました | Stifel | Buy |
| 2018-03-06 | 繰り返されました | Stifel | Buy |
| 2018-02-15 | 繰り返されました | SunTrust | Buy |
| 2018-01-23 | 繰り返されました | Credit Suisse | Outperform |
| 2017-11-15 | 開始されました | SunTrust | Buy |
| 2017-11-09 | 開始されました | Jefferies | Buy |
| 2017-10-11 | 繰り返されました | RBC Capital Mkts | Outperform |
| 2017-09-15 | 開始されました | RBC Capital Mkts | Outperform |
すべてを表示
Anaptysbio Inc (ANAB) 最新ニュース
TD Asset Management Inc Raises Stock Position in AnaptysBio, Inc. (NASDAQ:ANAB) - MarketBeat
A Guide To The Risks Of Investing In AnaptysBio Inc (ANAB) - Knox Daily
Bioventus Inc [BVS] stock for 683,736 USD was bought by Bartholdson John A. - Knox Daily
Insider Selling: Lizzul Paul F., AnaptysBio Inc [ANAB] Chief Medical Officer divested 2,000 shares - Knox Daily
BTIG Reiterates Buy Rating on Anaptysbio (ANAB) (correction) - StreetInsider.com
AnaptysBio (NASDAQ:ANAB) Shares Down 3.2% - MarketBeat
Analysts Set AnaptysBio, Inc. (NASDAQ:ANAB) Price Target at $50.30 - MarketBeat
AnaptysBio, Inc. (NASDAQ:ANAB) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Learn to Evaluate (ANAB) using the Charts - Stock Traders Daily
Anaptys Announces Participation in September Investor Conferences - ForexTV.com
Anaptys Announces Participation in September Investor Conferences - Yahoo Finance UK
Anaptys Announces Participation in September Investor Conferences - StockTitan
Why AnaptysBio Was Such a Healthy Stock This Week - sharewise
Why AnaptysBio Was Such a Healthy Stock This Week - Yahoo Finance
Alopecia Areata Clinical Trials 2024: FDA Approvals, Pipeline, - openPR
Contrasting AstraZeneca (NASDAQ:AZN) & AnaptysBio (NASDAQ:ANAB) - Defense World
AnaptysBio Inc (ANAB) receives a Buy rating from H.C. Wainwright - Knoxdaily.com
Hedge Fund and Insider Trading News: Carl Icahn, Ken Griffin, Warren Buffett, Engaged Capital, Elliott Management, Oslo Asset Management, AnaptysBio Inc (ANAB), and More - Insider Monkey
Guggenheim maintains buy on AnaptysBio shares, cites ANAB032 potential By Investing.com - Investing.com Canada
Insiders Buying Yum China And 2 Other Stocks - Benzinga
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Sold by California State Teachers Retirement System - Defense World
Short Interest in AnaptysBio, Inc. (NASDAQ:ANAB) Rises By 9.3% - Defense World
Ecor1 Capital, Llc Buys 273,972 Shares of AnaptysBio, Inc. (NASDAQ:ANAB) Stock - Defense World
AnaptysBio, Inc. (NASDAQ:ANAB) Shares Acquired by Assenagon Asset Management S.A. - MarketBeat
Assenagon Asset Management S.A. Has $7.68 Million Stock Holdings in AnaptysBio, Inc. (NASDAQ:ANAB) - Defense World
AnaptysBio, Inc. (NASDAQ:ANAB) Short Interest Update - MarketBeat
Anaptysbio chief medical officer executes stock transactions By Investing.com - Investing.com Australia
Truist Financial Increases AnaptysBio (NASDAQ:ANAB) Price Target to $30.00 - Defense World
AnaptysBio, Inc. to Post Q3 2024 Earnings of ($1.57) Per Share, HC Wainwright Forecasts (NASDAQ:ANAB) - Defense World
AnaptysBio (NASDAQ:ANAB) Stock Price Up 6.6% After Insider Buying Activity - Defense World
AnaptysBio, Inc. (NASDAQ:ANAB) Major Shareholder Ecor1 Capital, Llc Acquires 273,972 Shares - MarketBeat
Public Equity Report: AnaptysBio, Avidity draw nine-digit offerings - BioCentury
Anaptysbio chief medical officer executes stock transactions By Investing.com - Investing.com Canada
Anaptysbio chief medical officer executes stock transactions By Investing.com - Investing.com UK
AnaptysBio (NASDAQ:ANAB) Trading Up 6.6% Following Insider Buying Activity - MarketBeat
Q3 2024 Earnings Forecast for AnaptysBio, Inc. Issued By HC Wainwright (NASDAQ:ANAB) - MarketBeat
Nothing is Better Than AnaptysBio Inc (ANAB) stock at the moment - SETE News
AnaptysBio (NASDAQ:ANAB) Reaches New 12-Month High at $41.11 - Defense World
Metric Analysis: AnaptysBio Inc (ANAB)’s Key Ratios in the Limelight - The Dwinnex
AnaptysBio (NASDAQ:ANAB) Stock Price Down 4.6% - MarketBeat
AnaptysBio: Top-Line AD Data End Of 2024 Could Be Turning Point (NASDAQ:ANAB) - Seeking Alpha
AnaptysBio shares hold rating; price target raised on pipeline programs By Investing.com - Investing.com Canada
AnaptysBio’s (ANAB) Buy Rating Reaffirmed at HC Wainwright - Defense World
AnaptysBio shares hold rating; price target raised on pipeline programs By Investing.com - Investing.com UK
AnaptysBio (NASDAQ:ANAB) Price Target Raised to $30.00 - MarketBeat
AnaptysBio announces pricing of $100 million offering - The Pharma Letter
ANAB’s Financial Health: Exploring AnaptysBio Inc’s Debt-to-Equity Ratio of 1.79 - The InvestChronicle
AnaptysBio (NASDAQ:ANAB) Stock Rating Reaffirmed by HC Wainwright - MarketBeat
AnaptysBio Inc [ANAB] stock was sold by Lizzul Paul F. at the price of US$52500.0 - Knox Daily
AnaptysBio stock soars to 52-week high, hits $38.91 By Investing.com - Investing.com Canada
AnaptysBio (NASDAQ:ANAB) Sets New 12-Month High at $41.11 - MarketBeat
Anaptysbio Inc (ANAB) 財務データ
収益
当期純利益
現金流量
EPS
Anaptysbio Inc (ANAB) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Lizzul Paul F. | Chief Medical Officer |
Aug 14 '24 |
Sale |
40.00 |
2,000 |
80,000 |
11,618 |
| EcoR1 Capital, LLC | 10% Owner |
Aug 14 '24 |
Buy |
36.50 |
273,972 |
9,999,978 |
7,794,996 |
1.10%
1.27%
大文字化:
|
ボリューム (24 時間):